Intra-arterial infusion of [I-125]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo

被引:56
作者
Ghilardi, JR
Catton, M
Stimson, ER
Rogers, S
Walker, LC
Maggio, JE
Mantyh, PW
机构
[1] VET ADM MED CTR,MOL NEUROBIOL LAB 151,MINNEAPOLIS,MN 55417
[2] UNIV MINNESOTA,DEPT PSYCHIAT,MINNEAPOLIS,MN 55455
[3] UNIV TEXAS,MED BRANCH,DEPT ANESTHESIOL,GALVESTON,TX 77555
[4] HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOL PHARMACOL,BOSTON,MA 02115
[5] WARNER LAMBERT PARKE DAVIS,DIV NEUROL & NEURODEGENERAT DIS,ANN ARBOR,MI 48105
关键词
Alzheimer's disease; beta-amyloid; imaging; Saimiri sciureus; cerebral amyloid angiopathy; blood-brain barrier;
D O I
10.1097/00001756-199611040-00040
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
ALZHEIMER'S disease is characterized by extracellular amyloid deposits in the brain at both vascular sites (cerebrovascular amyloid, CVA) and within the neuropil (plaques). In the present study we demonstrated that brain amyloid of aged non-human primates is efficiently detected by [I-125]A beta in vitro, and assessed the detection of that amyloid in vivo by intravascular infusion of [I-125]A beta. Aged squirrel monkeys (Saimiri sciureus) were anesthetized and infused intra-arterially with [I-125]A beta, and sacrificed 2 h later. Analysis of the anterior frontal and temporal cortices by autoradiography demonstrated that [I-125]A beta was deposited on CVA and that essentially every amyloid deposit which could be detected with thioflavin S or anti-A beta antibodies was also labeled by [I-125]A beta. These experiments suggest that intravascular infusion of radiolabeled A beta can be used to detect and image amyloid deposits in the human AD brain.
引用
收藏
页码:2607 / 2611
页数:5
相关论文
共 22 条
[1]  
Claudio L, 1996, ACTA NEUROPATHOL, V91, P6
[2]   IMAGE-ANALYSIS OF BETA-AMYLOID LOAD IN ALZHEIMERS-DISEASE AND RELATION TO DEMENTIA SEVERITY [J].
CUMMINGS, BJ ;
COTMAN, CW .
LANCET, 1995, 346 (8989) :1524-1528
[3]   ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN [J].
GAMES, D ;
ADAMS, D ;
ALESSANDRINI, R ;
BARBOUR, R ;
BERTHELETTE, P ;
BLACKWELL, C ;
CARR, T ;
CLEMENS, J ;
DONALDSON, T ;
GILLESPIE, F ;
GUIDO, T ;
HAGOPIAN, S ;
JOHNSONWOOD, K ;
KHAN, K ;
LEE, M ;
LEIBOWITZ, P ;
LIEBERBURG, I ;
LITTLE, S ;
MASLIAH, E ;
MCCONLOGUE, L ;
MONTOYAZAVALA, M ;
MUCKE, L ;
PAGANINI, L ;
PENNIMAN, E ;
POWER, M ;
SCHENK, D ;
SEUBERT, P ;
SNYDER, B ;
SORIANO, F ;
TAN, H ;
VITALE, J ;
WADSWORTH, S ;
WOLOZIN, B ;
ZHAO, J .
NATURE, 1995, 373 (6514) :523-527
[4]   STUDIES WITH RADIOLABELED SERUM AMYLOID-P COMPONENT PROVIDE EVIDENCE FOR TURNOVER AND REGRESSION OF AMYLOID DEPOSITS IN-VIVO [J].
HAWKINS, PN .
CLINICAL SCIENCE, 1994, 87 (03) :289-295
[5]  
LEVY E, 1995, NEUROBIOL AGING, V5, P805
[6]   REVERSIBLE INVITRO GROWTH OF ALZHEIMER-DISEASE BETA-AMYLOID PLAQUES BY DEPOSITION OF LABELED AMYLOID PEPTIDE [J].
MAGGIO, JE ;
STIMSON, ER ;
GHILARDI, JR ;
ALLEN, CJ ;
DAHL, CE ;
WHITCOMB, DC ;
VIGNA, SR ;
VINTERS, HV ;
LABENSKI, ME ;
MANTYH, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5462-5466
[7]   PASSAGE OF HUMAN AMYLOID BETA-PROTEIN-1-40 ACROSS THE MURINE BLOOD-BRAIN-BARRIER [J].
MANESS, LM ;
BANKS, WA ;
PODLISNY, MB ;
SELKOE, DJ ;
KASTIN, AJ .
LIFE SCIENCES, 1994, 55 (21) :1643-1650
[8]  
MANTYH PW, 1995, J NEUROSCI, V15, P152
[9]  
MANTYH PW, 1989, J NEUROSCI, V9, P258
[10]  
MANTYH PW, 1991, B CLIN NEUROSCI, V56, P73